시장보고서
상품코드
2075853

당뇨병성 족부궤양 치료 시장 : 제품 유형별, 궤양 유형별, 최종 사용자별, 지역별

Diabetic Foot Ulcers Treatment Market, By Product, By Ulcer Type, By End User, By Geography

발행일: | 리서치사: 구분자 Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,500 금액 안내 화살표 ₩ 6,617,000
PDF & Excel (Multi User License - Up to 7 Users) help
PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 7,000 금액 안내 화살표 ₩ 10,294,000
PDF & Excel (Corporate User License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 금액 안내 화살표 ₩ 14,706,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

당뇨병성 족부궤양 치료 시장은 2026년에 103억 6,000만 달러 규모에 이를 것으로 추정되며, 2033년까지 207억 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 10.4%로 성장할 전망입니다.

보고서 범위 보고서 상세
기준 연도 : 2025년 시장 규모(2026년) : 103억 6,000만 달러
과거 데이터 기간 : 2020-2024년 예측 기간 : 2026-2033년
예측 기간 CAGR(2026-2033년) : 10.40% 시장 규모 예측(2033년) : 207억 달러

당뇨병성 족부궤양은 당뇨병 환자에게 흔히 나타나는 질환으로, 하지 절단으로 이어질 수 있습니다. 당뇨병 치료에 인슐린에 의존하고 계신 분들은 발 궤양이 발생할 위험이 높아집니다. 또한, 당뇨병과 관련된 신장 질환, 안과 질환, 심장 질환 및 비만을 앓고 있는 분들도 당뇨병성 족부 궤양을 발병할 가능성이 있습니다. 알코올이나 담배를 섭취하는 분들의 경우에도 이 질환의 발병 위험이 높아집니다. 당뇨병성 족부 궤양의 일반적인 초기 증상으로는 한쪽 또는 양쪽 발에 나타나는 비정상적인 부종, 발적, 자극감, 악취 등이 있습니다. 당뇨병성 족부궤양의 치료에는 일반적으로 혈당 관리, 괴사 조직 제거, 상처 덮개 적용 및 음압 요법이 포함됩니다.

시장 역학

세계 당뇨병성 족부궤양 치료 시장에서 사업을 전개하는 주요 기업들은 신제품 출시 및 규제 당국의 승인 획득과 같은 성장 전략을 채택하는 데 주력하고 있으며, 이러한 요인들이 예측 기간 동안 시장 성장을 견인할 것으로 전망됩니다. 예를 들어, 2019년 11월, 스웨덴에 본사를 둔 바이오의약품 기업 프로모어 파마 AB(Promore Pharma AB)의 자회사인 페르가뭄 AB(Pergamum AB)는 당뇨병성 족부 궤양 치료에 사용되는 제품 후보인 'PXL01' 제제에 대해 미국에서 특허를 취득했습니다. 또한, 2019년 12월에는 당뇨병성 족부 궤양 치료용 감각 깔창 시스템을 설계·개발하는 의료기기 기업인 Orpyx Medical Technologies Inc.가, 당뇨병성 족부 궤양 및 신경병증 관련 궤양의 예방을 목적으로 한 'Orpyx SI Sensory Insoles'를 발매했습니다. 또한, 2017년 12월에는 SANUWAVE Health Inc.가 당뇨병성 족부 궤양 치료를 적응증으로 하는 'Dermapace' 시스템에 대한 미국 내 판매 승인을 획득했습니다.

본 조사의 주요 특징 :

  • 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하는 한편, 세계 당뇨병성 족부 궤양 치료 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
  • 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
  • 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 세계 당뇨병성 족부 궤양 치료 시장의 주요 기업을 분석했습니다.
  • 본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
  • 이 책 '세계의 당뇨병성 족부 궤양 치료 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자들은 세계의 당뇨병성 족부 궤양 치료 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.

목차

제1장 조사 목적 및 전제조건

제2장 시장 전망

제3장 시장 역학, 규제 및 동향 분석

제4장 세계의 당뇨병성 족부궤양 치료 시장 : 제품별(2021-2033년)

제5장 세계의 당뇨병성 족부궤양 치료 시장 : 궤양 유형별(2021-2033년)

제6장 세계의 당뇨병성 족부궤양 치료 시장 : 최종 사용자별(2021-2033년)

제7장 세계의 당뇨병성 족부궤양 치료 시장 : 지역별(2021-2033년)

제8장 경쟁 구도

제9장 섹션

AJY 26.07.09

Diabetic Foot Ulcers Treatment Market is estimated to be valued at USD 10.36 Bn in 2026 and is expected to reach USD 20.70 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 10.36 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.40% 2033 Value Projection: USD 20.70 Bn

Diabetic foot ulcer is a common condition in diabetic patients, which may lead to amputation of the leg. People who rely on insulin for the treatment of diabetes are at high risk of developing a foot ulcer. Moreover, people suffering from diabetes-related kidney, eye, and heart disease and obesity can also suffer from diabetic foot ulcers. The risk of the disease is high in those consuming alcohol and tobacco. The common initial symptoms of diabetic foot ulcer include unusual swelling, redness, irritation, and stenches on one or both feet. Diabetic foot ulcer treatment, usually include control of blood sugar, removal of dead tissue, wound dressings, and negative pressure therapy.

Market Dynamics

Key players operating in the global diabetic foot ulcer treatment market are focusing on adoption of growth strategies such as product launches and regulatory approvals, which are expected to drive the market growth during the forecast period. For instance, in November 2019, Pergamum AB, a subsidiary of Promore Pharma AB, a Sweden-based biopharmaceutical company, received a patent in the U.S. for the pharmaceutical formulation of the product candidate PXL01 used for the treatment of diabetic foot ulcers. Moreover, in December 2019, Orpyx Medical Technologies Inc., a medical device company that designs and develops sensory insole systems for the treatment of diabetic foot ulcers, launched Orpyx SI Sensory Insoles with for the prevention of diabetic foot ulcers and neuropathy-related ulcers. Furthermore, in December 2017, SANUWAVE Health Inc., received the US approval for marketing of the Dermapace system, the indicated to treat diabetic foot ulcer.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for global diabetic foot ulcer treatment market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global diabetic foot ulcer treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include 3M Healthcare, B. Braun Melsungen AG, Smith & Nephew, Inc., Organogenesis, Inc., Derma Sciences Inc., Sigvaris Inc., Acelity L.P. Inc., Osiris, and Molnlycke Health Care AB
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global diabetic foot ulcer treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetic foot ulcer treatment market

Detailed Segmentation:

  • Global Diabetic Foot Ulcer Treatment Market, By Product (Revenue, USD Bn, 2021 - 2033)
  • Advance Wound Dressings
  • Skin Substitutes
  • Growth Factors
  • Negative Pressure Wound Therapy Devices
  • Other Devices
  • Global Diabetic Foot Ulcer Treatment Market, By Ulcer Type (Revenue, USD Bn, 2021 - 2033)
  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuro-ischemic Ulcers
  • Global Diabetic Foot Ulcer Treatment Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Long Term Care Centers
  • Ambulatory Surgical Center
  • Global Diabetic Foot Ulcer Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
  • North America
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Product
      • Advance Wound Dressings
      • Skin Substitutes
      • Growth Factors
      • Negative Pressure Wound Therapy Devices
      • Other Devices
    • By Ulcer Type
      • Neuropathic Ulcers
      • Ischemic Ulcers
      • Neuro-ischemic Ulcers
    • By End User
      • Hospitals
      • Specialty Clinics
      • Long Term Care Centers
      • Ambulatory Surgical Center
    • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
  • 3M Healthcare*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Braun Melsungen AG
  • Smith & Nephew, Inc.
  • Organogenesis, Inc.
  • Derma Sciences Inc.
  • Sigvaris Inc.
  • Acelity L.P. Inc.
  • Osiris
  • Molnlycke Health Care AB

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Product
    • Market Snippet, By Ulcer Type
    • Market Snippet, By End User
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Test Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Diabetic Foot Ulcers Treatment Market, By Product, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Advance Wound Dressings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Skin Substitutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Growth Factors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Negative Pressure Wound Therapy Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Other Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends

5. Global Diabetic Foot Ulcers Treatment Market, By Ulcer Type, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Neuropathic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Ischemic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Neuro-ischemic Ulcers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends

6. Global Diabetic Foot Ulcers Treatment Market, By End User, 2021-2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Hospital
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Long Term Care Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
    • Segment Trends

7. Global Diabetic Foot Ulcers Treatment Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021-2033, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Product, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Ulcer Type, 2021-2033, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By End User, 2021-2033, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2021-2033, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • 3M Healthcare*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Braun Melsungen AG
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Smith & Nephew, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Organogenesis, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Derma Sciences Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Sigvaris Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Acelity L.P. Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Osiris
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Molnlycke Health Care AB
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Alkem Laboratories Ltd.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Healthium Medtech
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Kerecis
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Podimetrics
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Carmell Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Paracrine, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • VIVEX Biologics, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • PolarityTE, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기